M

MeiraGTx Holdings plc
D

MGTX

6.04500
USD
-0.38
(-5.84%)
مغلق
حجم التداول
12,501
الربح لكل سهم
3
العائد الربحي
-
P/E
-5
حجم السوق
472,437,309
أصول ذات صلة
الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.